PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524280
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524280
Reconstructed Skin Models Market - Type (Reconstructed Human Epidermis, Reconstructed Human Skin), Application (Skin Irritation, Corrosion, Sensitization, Biopsy, Radioallergosorbent, & Pigmentation Test), End User, Global Forecast (2024 - 2032)
Global Reconstructed Skin Models Market size will record 14.6% CAGR from 2024 to 2032, driven by the increasing demand for personalized medicine and rapid advancements in technology. As healthcare transitions towards individualized treatments, reconstructed skin models offer a tailored approach for safety and efficacy testing while aligning with the need for precision medicine.
Moreover, the ongoing advancements in tissue engineering and biotechnology are bolstering the precision and dependability of these models, making them indispensable for the pharmaceutical, cosmetic, and biotechnology sectors in pursuit of the increasingly predictive and ethical testing methodologies. For instance, in July 2023, LOreal partnered with UC Berkeley's Baker Labs for offering select start-ups access to its 3D reconstructed skin models. This collaboration provided innovative companies with free access to LOreals advanced non-animal testing solutions for safety and efficacy testing.
The reconstructed skin models market is segmented on the basis of type, application, end-user, and region.
By type, the reconstructed human skin segment will capture considerable industry share by 2032, owing to its close resemblance to natural human skin for providing highly accurate and reliable results for safety and efficacy testing. The progress in tissue engineering methodologies has facilitated the creation of intricately reconstructed human skin models that closely replicate the intricate structure and functions of natural skin.
Based on application, the reconstructed skin models industry from the skin sensitization test segment will witness significant growth by 2032 due to rising awareness regarding the adverse effects of chemical exposure and the need for accurate and ethical testing methods. Reconstructed skin models offer a reliable platform for assessing skin sensitization potential without the need for animal testing. With regulatory pressures advocating alternative testing methods and industries prioritizing safety, the demand for skin sensitization tests employing reconstructed skin models will rise.
North America reconstructed skin models industry size will demonstrate a remarkable CAGR from 2024 to 2032, attributed to the advanced healthcare infrastructure, extensive R&D activities, and stringent regulatory frameworks. Additionally, the presence of key market players is increasing the investments in biotechnology and pharmaceutical sectors. With the growing emphasis on ethical testing methods and safety regulations, North America will stand out as a significant contributor to the market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising adoption of alternative testing procedures to animal testing
- 3.2.1.2 Increasing prevalence of skin disorders
- 3.2.1.3 Growing focus on precision cosmetic products
- 3.2.1.4 Growing investments in the development of advanced in-vitro models
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Concerns related to reproducibility across different batches
- 3.2.2.2 Presence of stringent regulatory approval process
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Reconstructed human epidermis
- 5.3 Reconstructed human skin
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Skin irritation test
- 6.3 Skin corrosion test
- 6.4 Skin sensitization test
- 6.5 Skin biopsy
- 6.6 Radioallergosorbent test
- 6.7 Skin pigmentation test
- 6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Cosmetics and cosmeceutical companies
- 7.3 Chemical companies
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 AIVITA Biomedical, Inc.
- 9.2 BICO - THE BIO CONVERGENCE COMPANY
- 9.3 CELLnTEC
- 9.4 EPISKIN
- 9.5 Henkel AG & Co. KGaA
- 9.6 Japan Tissue Engineering Co., Ltd.
- 9.7 Mallinckrodt plc
- 9.8 STRATICELL
- 9.9 WEPREDIC Group (Biopredic International)
- 9.10 ZenBio, Inc.
